On a Mission to Promote Dental Therapy
Amy Coplen, RDH, EPDH, MS, leads the charge in Oregon to implement dental therapy as a piece to solving the access-to-care puzzle.
Author
COVID-19 Cases in the United States Reach a New Low
The number of new COVID-19 infections in the United States hit a new low on May 20 with an average of fewer than 30,000 cases reported over the past 7 days. Over the past 2 weeks, new cases have fallen by more than 35%. Nearly 40% of…
Number of Deaths Due to COVID-19 Probably Grossly Underestimated
The World Health Organization (WHO) announced that the number of deaths across the globe attributed to COVID-19 is most likely two times to three times higher than the official figure given. WHO suggested that the COVID-19 death toll in…
Four States Add COVID-19 Lotteries to Boost Vaccination Rates
Ohio, Maryland, New York, and Oregon are offering lotteries worth millions of dollars to increase vaccination rates. On May 13, Ohio Governor Mike DeWine announced that Ohio residents ages 18 and older who receive a COVID-19 vaccination…
OSHA to Issue COVID-19-Related Standards to Protect Workers
The United States Occupational Safety and Health Administration (OSHA) is set to implement an emergency temporary standard (ETS) to protect workers in light of the COVID-19 pandemic. While the content of the ETS is currently unknown, some…
HHS to Close Payment Gap for COVID-19 Vaccinations
The United States Department of Health and Human Services (HHS) will provide reimbursement to vaccine providers for underinsured patients whose health plans do not cover immunizations. The HHS will use funds from the federal COVID-19…
NIH Study Better Elucidates How Our Bodies Fight SARS-CoV-2
Recent results from a National Institutes of Health (NIH) study demonstrate that the body unleashes a large number of antibodies in response to infection with the novel coronavirus. Published in Science, the article looked at the antibodies…
A New Entry to the COVID-19 Vaccine Armamentarium Shows Promise
A COVID-19 vaccine created through a partnership between Sanofi and GSK showed promising results in a Phase 2 clinical trial. A recombinant protein vaccine, it targets the SARS-CoV-2 spike protein, created via insect cells, with an antibody…
Scientists Suggest the Origins of SARS-CoV-2 Remain a Mystery
Many scientists believe the origins of the novel coronavirus remain unknown, and that no door should be shut as worldwide investigations continue. A group of scientists penned a letter to the highly regarded journal Science about keeping an…
Among Older Adults, a Longer Interval Between Pfizer Doses May Increase Antibody Response
New research from the United Kingdom finds that when older adults waited 12 weeks before receiving their second dose of the Pfizer COVID-19 vaccine, the resultant level of antibodies produced was 3.5 times higher than among those who…
